
1
Total Mentions
1
Documents
0
Connected Entities
American multinational biotechnology company
HOUSE_OVERSIGHT_024003 - HOUSE_OVERSIGHT_024116
number of private investments. These have included Cerexa (NLV-I, exited in sale to Forest Labs, 5.4x multiple), Stromedix (NLV-I, exited in sale to Biogen Idec, 1.8x multiple plus milestones), Chimerix (NLV-IL, IPO - April, 2013, NASDAQ: CMRxX), and Auxilium (Sprout IX, NASDAQ: AUXL, exited at 4.6x). e
Page: HOUSE_OVERSIGHT_024045 →No connected entities